Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2022 Sep;3(9):1137.
doi: 10.1038/s43018-022-00420-y.

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

Thomas Walle #  1   2   3 , Sunanjay Bajaj #  4   5 , Joscha A Kraske  5 , Thomas Rösner  5 , Christiane S Cussigh  6 , Katharina A Kälber  6 , Lisa Jasmin Müller  7 , Sophia Boyoung Strobel  6 , Jana Burghaus  6 , Stefan M Kallenberger  5 , Christoph K Stein-Thöringer  5   8 , Maximilian Jenzer  5 , Antonia Schubert  5   9   10   11 , Steffen Kahle  5 , Anja Williams  5 , Birgit Hoyler  4 , Lin Zielske  12 , Renate Skatula  12 , Stefanie Sawall  4 , Mathias F Leber  4   5 , Russell Z Kunes  13 , Johannes Krisam  14 , Carlo Fremd  5   15 , Andreas Schneeweiss  15 , Jürgen Krauss  5 , Leonidas Apostolidis  5 , Anne Katrin Berger  5 , Georg M Haag  5   16 , Stefanie Zschäbitz  5 , Niels Halama  5   17   18 , Christoph Springfeld  5 , Romy Kirsten  12 , Jessica C Hassel  6 , Dirk Jäger  5   16 ; NCT ANTICIPATE Investigators; Guy Ungerechts  4   5   19   20
Collaborators, Affiliations
Published Erratum

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

Thomas Walle et al. Nat Cancer. 2022 Sep.
No abstract available

PubMed Disclaimer

Erratum for

  • Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
    Walle T, Bajaj S, Kraske JA, Rösner T, Cussigh CS, Kälber KA, Müller LJ, Strobel SB, Burghaus J, Kallenberger SM, Stein-Thöringer CK, Jenzer M, Schubert A, Kahle S, Williams A, Hoyler B, Zielske L, Skatula R, Sawall S, Leber MF, Kunes RZ, Krisam J, Fremd C, Schneeweiss A, Krauss J, Apostolidis L, Berger AK, Haag GM, Zschäbitz S, Halama N, Springfeld C, Kirsten R, Hassel JC, Jäger D; NCT ANTICIPATE Investigators; Ungerechts G. Walle T, et al. Nat Cancer. 2022 Sep;3(9):1039-1051. doi: 10.1038/s43018-022-00398-7. Epub 2022 Jun 17. Nat Cancer. 2022. PMID: 35715501 Free PMC article.

Publication types